Just last year, Olga lost her husband to brain cancer after being told by doctors that the current tools and technology would be insufficient in helping her husband recover from his diagnosis. Brain cancer treatment and research is complicated by the blood-brain barrier, which is designed to keep chemicals in the blood from getting into the brain, including anti-cancer treatments. The loss of her husband made her acutely aware of the need for continued biopharmaceutical innovation and where treatments are available, for patients to access them.
After the loss of her husband, Olga became committed to supporting and protecting medical innovation by advocating against legislation that could stifle the development of new, life-saving treatments. She has also become a key advocate for protecting access to new innovations, as she knows just how critical they can be for patients with life-threatening diagnoses.
She values the work that the biopharmaceutical industry is doing to help put an end to the COVID-19 pandemic, as she herself contracted the virus in early 2020 and was vaccinated as soon as she was able. Olga feels blessed to have received her vaccination, and now, she wants to help the biopharmaceutical industry put the pandemic behind us by protecting the innovation that has made an end in sight possible.
At a time when new developments by the biopharmaceutical industry are critical, Olga is disappointed that policymakers in Congress are pushing for changes that would impact the medical innovation and access that she values so much. Government price setting would have negative consequences for biopharmaceutical innovation and patient access, and Olga is fiercely opposed to measures that puts those values at risk.
As a mother of three, grandmother of six, and great-grandmother of three, Olga is committed to advocating for continued innovation so that future generations can have access to even more life-saving treatments and cures.
Join Olga and take action today.
